论文信息 - Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4– and PD-1–targeted immunotherapy - 字舞流文

Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4– and PD-1–targeted immunotherapy

Yang Liu | P. Zhang | L. Su | Juanjuan Su | P. Zheng | Wei Wu | Musleh M. Muthana | Yan Zhang | M. Devenport | Xu Wang | Mingyue Liu | Xuexiang Du | Chunxia Ai